Tag: Generics

Rare Disease Momentum and Generics Expansion Drive Upgraded Outlook

Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ: ANIP) recently announced its Q3 CY2025 results, surpassing market expectations with a…